ID
25692
Beschrijving
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced
Trefwoorden
Versies (2)
- 10-09-17 10-09-17 -
- 10-09-17 10-09-17 -
Geüploaded op
10 september 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Beschrijving
Eligibility
Alias
- UMLS CUI-1
- C0013893
Beschrijving
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Beschrijving
healthy between 18 and 55 years
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3898900
- UMLS CUI [1,2]
- C0001779
Beschrijving
childbearing potential
Datatype
boolean
Alias
- UMLS CUI [1]
- C3831118
Beschrijving
BMI
Datatype
boolean
Alias
- UMLS CUI [1]
- C1305855
Beschrijving
informed consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
screening finding
Datatype
boolean
Alias
- UMLS CUI [1]
- C1409616
Beschrijving
allergy dexamethasone
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0013182
- UMLS CUI [1,2]
- C0011777
Beschrijving
osteoporosis
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0029456
- UMLS CUI [1,2]
- C1141639
Beschrijving
concomitant medication
Datatype
boolean
Alias
- UMLS CUI [1]
- C2347852
Beschrijving
medical history
Datatype
boolean
Alias
- UMLS CUI [1]
- C0262926
Beschrijving
medical history
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0205082
Beschrijving
cytochrome P450 3A inducer or inhibitors
Datatype
boolean
Alias
- UMLS CUI [1]
- C3830625
- UMLS CUI [2]
- C3830624
Beschrijving
herbal or dietary supplements
Datatype
boolean
Alias
- UMLS CUI [1]
- C0242295
- UMLS CUI [2]
- C1504473
Beschrijving
blood donor
Datatype
boolean
Alias
- UMLS CUI [1]
- C0005795
Beschrijving
investigational drug
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschrijving
drug screeing
Datatype
boolean
Alias
- UMLS CUI [1]
- C0743295
Beschrijving
alcohol consumption
Datatype
boolean
Alias
- UMLS CUI [1]
- C0001948
Beschrijving
smoking
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543414
Beschrijving
HIV, Hepatitis B or Hepatitis C test positive
Datatype
boolean
Alias
- UMLS CUI [1]
- C1321876
- UMLS CUI [2]
- C2363788
- UMLS CUI [3]
- C2363789
Similar models
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
C0040223 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])
C0001779 (UMLS CUI [1,2])
C0011777 (UMLS CUI [1,2])
C1141639 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C3830624 (UMLS CUI [2])
C1504473 (UMLS CUI [2])
C2363788 (UMLS CUI [2])
C2363789 (UMLS CUI [3])